|
|
|
| |
|
|
| |
The latest clinical and lab diagnostics news from News Medical |
|
|
|
| |
 Citrine system compendium
Run clinical diagnostic assays with confidence. The Citrine system compendium includes 22 analytical performance datasheets showcasing the benefits of the Citrine system for challenging assays. Discover the ease of implementing LC-MS/MS and learn how to reliably measure low-level biomarkers with precision and accuracy. Download now to empower your lab.
| |
|
|
| |  | | |  Researchers analyzed health records from over 1 million people in Finland, Wales, and the UK to assess the long-term impact of sleep disorders on neurodegenerative diseases. They found that diagnosed sleep disorders can predict Alzheimer’s, Parkinson’s, and dementia risk up to 15 years before symptoms, regardless of genetic predisposition. | | | | |  In a large Norwegian study, a commercial AI tool analyzed routine mammograms and identified women at elevated risk of developing breast cancer up to 4–6 years before diagnosis. These AI-generated risk scores may help personalize breast cancer screening and facilitate earlier interventions. | | | | |  Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early detection to improve survival rates and reduce treatment invasiveness. | | | | |  Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), following treatment with the KRAS targeted therapy sotorasib. | | | | |  A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care. | | | | |  A new study, led by experts at the University of Nottingham, has found that young people suffering from certain types of cancer, such as bone tumors, are experiencing lengthy times to diagnosis. | | | | |  Scientists have discovered a range of 'biomarkers' that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD). | | | | |  Imagine diagnosing cancer not with a supercomputer but on an ordinary laptop instead. Sounds like science fiction? Thanks to a revolutionary artificial intelligence (AI) model developed by Professor Kenji Suzuki and his research team from Institute of Science Tokyo (Science Tokyo), this far-fetched scenario is now a reality. | | | | |  Artificial intelligence is playing an increasingly vital role in modern medicine, particularly in interpreting medical images to help clinicians assess disease severity, guide treatment decisions and monitor disease progression. | | | | |  Scientists at the National Institutes of Health (NIH) have found that levels of circulating taurine, a conditionally essential amino acid involved in multiple important biological functions, is unlikely to serve as a good biomarker for the aging process. | |
|
|
| | | How would you rate today's newsletter?
| |
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
